Abstract: The Supernova line by Vida Pharma, launched in 2024, introduces a revolutionary approach to skin regeneration and needle-free biorevitalization. Centered on patented biphasic chemical peels-Nebula ACTO2 and Nebula ACTO2 ORION-these medical devices represent a significant advancement in dermatological treatments. This article reviews the scientific rationale, innovative formulation, mechanisms of action, clinical efficacy and safety.

1. Introduction

In the evolving landscape of aesthetic medicine, the demand for non-invasive yet effective skin regeneration solutions is at an all-time high. Existing biorevitalization modalities, notably those leveraging trichloroacetic acid (TCA), have provided promising alternatives to traditional needling or injectable approaches. However, the introduction of Supernova biphasic peelings in 2024 marks a pivotal shift-merging advanced chemical technology, safety, and convenience without compromising results.

2. Technology and Scientific Rationale

The brand Supernova by Vida Pharma is founded on the principle that scientific progress must serve personal well-being, combining rigorous internal research and development with strict adherence to international quality standards (UNI EN ISO 13485, ISO 22716).

Innovation in Peeling: Unlike monophasic peels, Supernova's biphasic approach divides the active ingredients into two distinct but synergistic phases: an acid phase (exfoliation) and an oxygenating phase (soothing and tissue repair), creating instant cell renewal and significant dermo-epidermal regeneration without aggressive exfoliation.

3. Composition and Mechanisms of Action

Key Suite of Products:

• Nebula ACTO2: Biphasic TCA 10% peel with mandelic acid, Vitamin B12, azelaic acid derivative, perfluorocarbons for mild to moderate skin issues.
• Nebula ACTO ORION: Biphasic TCA 14% peel for more intense exfoliation and pigment correction.
• A post-treatment cream, RH VIRGO, containing perfluorodecalin, plankton extract, avocado oil, shea butter, Vitamin E, and sunscreens, is included to support recovery and further soothe the skin.

Active Ingredients and effects:

• Trichloroacetic Acid (TCA): provides exfoliation and stimulates new cell growth;
• Mandelic Acid: enhances cell turnover and brightening, helping to reduce epidermal pigmentation;
• Azelaic Acid Derivative: offers anti-inflammatory and anti-comedogenic effects;
• Vitamin B12: promotes cell repair and barrier integrity;
• Perfluorocarbons (oxygenating phase): support tissue oxygenation and healing, minimizing post-peel irritation.

Biphasic Mechanism: The dual-phase system ensures:

• Controlled, non-aggressive exfoliation;
• Significant yet well-tolerated keratolytic (stratum corneum removal) activity;
• Immediate cell renewal and enhanced skin tolerability;
• Lower risk of photosensitization; treatment is suitable for all skin types and areas.

4. Clinical Efficacy and Scientific Data

In Vitro and Comparative Studies: Supernova peels have undergone both in vitro and comparative studies against competitive products with higher acid concentrations:

• Keratolytic Effect: Nebula ACTO2 demonstrated up to 12% higher stratum corneum removal than competitors, indicative of superior, yet controlled, exfoliation.
• Increased Skin Dryness: A 10% increase versus products with higher acid content, correlating with efficient keratolysis but without excessive irritation.
• Side Effects: Despite its higher exfoliating power, side effects matched those of competitors-transient, mild, resolving within hours.
• Anti-Inflammatory Effect: Significant reduction of pro-inflammatory interleukin-1a (IL-1alpha) by 14.4% and 13.7% at 1.0 and 0.5 mg/ml, respectively, surpassing competitor products that failed to achieve similar anti-inflammatory results.

5. Indications and Areas of Application

Versatility: Supernova biphasic peels are indicated for a wide spectrum of dermatological and aesthetic purposes:

• Acne (acute, comedonal, post-acne)
• Pigmentation disorders: effective depigmenting and tone-correcting actions
• General skin imperfections and dyschromia
• Biorevitalization (anti-aging): fine lines, wrinkles, and superficial laxity
• Stimulation of collagen production
• Post-procedure skin recovery: especially when combined with fillers, as in dual protocols with Opéra skinfillers for acne scars and skin texture remodeling.

6. Protocol, Timing, and Safety

Treatment Protocol:

• Rapid treatment times with little to no downtime.
• No photosensitization: year-round application.
• Safe for all skin types: Including sensitive and combination skin.
• Post-treatment RH VIRGO cream: Soothes and protects, ensuring optimal recovery.

• Minimized risk: all observed side effects are mild and resolve quickly, thanks to the innovative biphasic formulation.
• Dermatologically tested: particularly on sensitive skins.

7. Conclusion

The Supernova biphasic peeling line represents a disruptive advancement in aesthetic medicine. Through carefully engineered chemistry and a biphasic delivery system, Vida Pharma offers clinicians and patients a robust, scientifically validated alternative to both traditional and contemporary needle-free biorevitalization methods. The result: faster, safer, and more versatile rejuvenation for all skin types and areas, with a particular edge over market competitors due to its unique effects on cell turnover, inflammation, and recovery.

Want to know more? Check: https://k-surgerymed.com/